Endo Pharmaceuticals (ENDP) Acquires RxKinetix, Inc. Deal Worth Potentially $95 Million
10/13/2006 9:39:57 AM
More...
|
RxKinetix, Inc. Completes Its End Of Phase 2 Meeting With The FDA For RK-0202 In Oral Mucositis And Is Moving Into Phase 3
3/1/2006 10:21:31 AM
More...
|
RxKinetix, Inc. Receives University of Colorado Technology Transfer Life Sciences Company Of The Year Award
1/13/2006 10:21:47 AM
More...
|
RxKinetix, Inc. And Indian Immunologicals Limited Collaborate On Development Of Thermostable Hepatitis B Vaccines
11/2/2005 1:12:38 PM
More...
|
RxKinetix, Inc. Successfully Concludes Its Phase 2 Trial In Oral Mucositis
10/19/2005 5:13:22 PM
More...
|
RxKinetix, Inc. Has Been Offered A Grant From The Prestigious Grand Challenges In Global Health Initiative To Develop Vaccines With Improved Stability At Non-Refrigerated Temperatures
10/19/2005 5:09:24 PM
More...
|